{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T18:47:52Z","timestamp":1759776472842},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T00:00:00Z","timestamp":1501113600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1038\/nrrheum.2017.116","type":"journal-article","created":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T10:01:59Z","timestamp":1501149719000},"page":"516-518","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Breaking Prometheus's curse for cartilage regeneration"],"prefix":"10.1038","volume":"13","author":[{"given":"Florence","family":"Apparailly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,27]]},"reference":[{"key":"BFnrrheum2017116_CR1","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.stemcr.2017.03.022","volume":"8","author":"JM Brunger","year":"2017","unstructured":"Brunger, J. M., Zutshi, A., Willard, V. P., Gersbach, C. A. & Guilak, F. Genome engineering of stem cells for autonomously regulated, closed-loop delivery of biologic drugs. Stem Cell Reports 8, 1202\u20131213 (2017).","journal-title":"Stem Cell Reports"},{"key":"BFnrrheum2017116_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrrheum.2009.182","volume":"5","author":"RF van Vollenhoven","year":"2009","unstructured":"van Vollenhoven, R. F. Treatment of rheumatoid arthritis: state of the art 2009. Nat. Rev. Rheumatol. 5, 531\u2013541 (2009).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum2017116_CR3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrrheum.2014.212","volume":"11","author":"C Hinze","year":"2015","unstructured":"Hinze, C., Gohar, F. & Foell, D. Management of juvenile idiopathic arthritis: hitting the target. Nat. Rev. Rheumatol. 11, 290\u2013300 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum2017116_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrrheum.2012.176","volume":"9","author":"F Apparailly","year":"2013","unstructured":"Apparailly, F. & Jorgensen, C. siRNA-based therapeutic approaches for rheumatic diseases. Nat. Rev. Rheumatol. 9, 56\u201362 (2013).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum2017116_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3109\/s10165-007-0017-9","volume":"18","author":"RS Traister","year":"2008","unstructured":"Traister, R. S. & Hirsch, R. Gene therapy for arthritis. Mod. Rheumatol. 18, 2\u201314 (2008).","journal-title":"Mod. Rheumatol."},{"key":"BFnrrheum2017116_CR6","doi-asserted-by":"publisher","first-page":"19442","DOI":"10.1073\/pnas.0604827103","volume":"103","author":"H Le Buanec","year":"2006","unstructured":"Le Buanec, H.  et al. TNF\u03b1 kinoid vaccination-induced neutralizing antibodies to TNF\u03b1 protect mice from autologous TNF\u03b1-driven chronic and acute inflammation. Proc. Natl Acad. Sci. USA 103, 19442\u201319447 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum2017116_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2165\/11595490-000000000-00000","volume":"25","author":"S Fabre","year":"2011","unstructured":"Fabre, S. & Apparailly, F. Gene therapy for rheumatoid arthritis: current status and future prospects. BioDrugs 25, 381\u2013391 (2011).","journal-title":"BioDrugs"},{"key":"BFnrrheum2017116_CR8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jbspin.2015.03.002","volume":"82","author":"C Aalbers","year":"2015","unstructured":"Aalbers, C.  et al. Intra-articular etanercept treatment in inflammatory arthritis: a randomized double-blind placebo-controlled proof of mechanism clinical trial validating TNF as a potential therapeutic target for local treatment. Joint Bone Spine 82, 338\u2013344 (2015).","journal-title":"Joint Bone Spine"},{"key":"BFnrrheum2017116_CR9","doi-asserted-by":"publisher","first-page":"e0130612","DOI":"10.1371\/journal.pone.0130612","volume":"10","author":"CJ Aalbers","year":"2015","unstructured":"Aalbers, C. J.  et al. Preclinical potency and biodistribution studies of an AAV 5 vector expressing human interferon-\u03b2 (ART-I02) for local treatment of patients with rheumatoid arthritis. PLoS ONE 10, e0130612 (2015).","journal-title":"PLoS ONE"},{"key":"BFnrrheum2017116_CR10","doi-asserted-by":"publisher","first-page":"847","DOI":"10.5966\/sctm.2015-0245","volume":"5","author":"YM Pers","year":"2016","unstructured":"Pers, Y. M.  et al. Adipose mesenchymal stromal cell-based therapy for severe osteoarthritis of the knee: a phase I dose-escalation trial. Stem Cells Transl. Med. 5, 847\u2013856 (2016).","journal-title":"Stem Cells Transl. Med."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2017.116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2017.116","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrrheum.2017.116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2017.116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:40:39Z","timestamp":1684471239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2017.116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["BFnrrheum2017116"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2017.116","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,27]]},"assertion":[{"value":"27 July 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}